[ JAK2 mutation in myeloproliferative neoplasms: a predictive factor of thrombosis]
Tunisie Medicale [La]. 2015; 93 (7): 474-477
in French
| IMEMR
| ID: emr-177380
ABSTRACT
Background:
BCR-ABL negative myeloproliferative neoplasms [MPN] include polycythemia Vera [PV], essential thrombocythemia [ET] and primitive myelofibrosis [PMF]. the JAK2 V617F mutation has been introduced since 2008 as a major diagnostic criterion on the one hand and on the other hand, it would be linked to increased risk of thrombotic complications
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
French
Journal:
Tunisie Med.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS